PostEra

PostEra, founded in 2019, bases its technology on the groundbreaking academic research conducted by its founding scientists. PostEra’s technology addresses some of the key challenges in drug discovery R&D by integrating molecular design with chemical synthesis. PostEra advances small molecule projects through collaborations with biopharmaceutical companies, develops its own internal pipeline, and offers some synthetic technologies via its Manifold web platform. PostEra uses machine learning to close the design-make-test cycle in drug discovery and reduce cycle times for clients. It is currently leading an international team of scientists in finding COVID antiviral drugs through open science methods.